MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience Anteile 2011-2026 | VIVO
Anteile Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.6 M | 43.3 M | 42.9 M | 42.6 M | 42.3 M | 42.2 M | 42 M | 41.7 M | 41.5 M | 41.2 M | 41.1 M | 40.7 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 43.6 M | 40.7 M | 42.1 M |
Anteile Vierteljährlich Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.9 M | 43.8 M | - | 43.5 M | 43.4 M | 43.4 M | 43.3 M | 43.2 M | 43.1 M | 42.8 M | 42.8 M | 43.1 M | 42.8 M | 42.5 M | 42.6 M | 42.8 M | 42.4 M | 42.3 M | 42.3 M | 42.4 M | 42.3 M | 42.2 M | 42.2 M | 42.3 M | 42.2 M | 42 M | 42.1 M | 42.2 M | 41.9 M | 41.6 M | 41.7 M | 41.9 M | 41.6 M | 41.4 M | 41.5 M | 41.6 M | 41.4 M | 41.2 M | 41.3 M | 41.4 M | 41.1 M | 41.1 M | 41.1 M | 41.1 M | 41.1 M | 40.7 M | 40.7 M | 41.1 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 43.9 M | 40.7 M | 42.1 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
304 M | $ 121.25 | 2.54 % | $ 36.9 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 21.33 | -5.2 % | $ 230 M |  China |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 22.09 | -1.47 % | $ 1.18 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.52 | 4.12 % | $ 2.02 M | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 25.08 | 2.13 % | $ 697 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 183.47 | 3.69 % | $ 9.09 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 195.86 | 1.07 % | $ 140 B | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 2.0 | -9.09 % | $ 8.85 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 519.83 | 0.81 % | $ 15 B | USA |
 |
Illumina
ILMN
|
159 M | $ 134.35 | 1.23 % | $ 21.4 B | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 5.19 | 3.7 % | $ 481 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 8.38 | 2.63 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.64 | 4.33 % | $ 2.09 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 16.34 | 1.3 % | $ 494 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 29.83 | 4.17 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
1.61 M | $ 28.81 | -0.66 % | $ 46.2 M | USA |
 |
Guardant Health
GH
|
125 M | $ 90.83 | 5.99 % | $ 11.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.83 | - | $ 91.8 K | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.18 | -0.91 % | $ 5.01 M | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 119.42 | 3.32 % | $ 9.85 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 273.05 | 2.51 % | $ 22.7 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 6.8 | 0.44 % | $ 284 M | USA |
 |
Celcuity
CELC
|
46.8 M | $ 123.43 | -1.45 % | $ 5.77 B | USA |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.67 | 0.18 % | $ 2.68 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 84.14 | 0.26 % | $ 5.68 B | USA |
 |
Neuronetics
STIM
|
66 M | $ 1.44 | 2.86 % | $ 95 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 195.61 | 2.17 % | $ 21.7 B | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 6.01 | 16.27 % | $ 4.73 M | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 526.97 | 2.13 % | $ 199 B | USA |
 |
Trinity Biotech plc
TRIB
|
83.6 M | $ 0.68 | -2.63 % | $ 61.9 M | Irlanda |